Skip to content

Dr. Amalia Ruiz Estrada

Information about Dr. Amalia Ruiz Estrada at the University of Bradford.

Some details are missing for this profile, including contact information. If this is your profile, please review guidance on how to report this issue.

Photo of Dr. Amalia Ruiz Estrada


Dr Ruiz graduated in Biochemistry from the University of Havana, Cuba. She completed her PhD in Advanced Materials and Nanotechnology at the Autonomous University of Madrid. Her PhD research project focused on developing magnetic nanoparticles for different biotechnological and biomedical applications. Previously, Dr Ruiz held different postdoctoral positions across Cuba and Europe. In 2014 she joined the Centre for Advanced Studies in Cuba to investigate novel formulations of iron oxide nanoparticles and their toxicological evaluation in different in vitro and in vivo models. In 2016, she joined the University of East Anglia in Norwich as Senior Research Associate (Marie Skłodowska-Curie Fellow) to work in the DNA-TRAP EU funded project to develop a range of antimicrobial nanoformulations and assess their therapeutic efficacy in in vitro models. Later, she moved to the Molecular and Cellular Biology Institute in Strasbourg to be part of the Graphene Flagship project, the European Union's biggest scientific research initiative, to assess the pharmacological behaviour of different graphene-based materials and their innovative application in cancer treatment. In November 2018, she started at the School of Pharmacy at Queen’s University Belfast, where her research was focused on the development of smart nanocarriers for targeted cancer therapy, as well as engineering novel nanoformulations to detect and treat aggressive metastatic prostate cancer. Currently, Dr Ruiz’s research focuses on the fabrication of multifunctional nanomaterials to target cancer and other diseases, developing novel nanomedicines for combinatory therapy and theragnostic applications and the safety evaluation of these nanomaterials applied to human health. Her long-term research career objective is to facilitate the translation of nanoparticle-based therapeutics from the lab to the clinic.


I'm always open to PhD applications in the field of Nanomedicine, drug delivery systems, smart nanomaterials, nanotoxicology, hyperthermia, photothermal, photodynamic therapy, combination therapies and theragnostic applications


There are 1 publications involving or that are attributed to Dr. Amalia Ruiz Estrada.

Uncategorised publications

Dr. Amalia Ruiz Estrada has 1 publication(s) listed under uncategorised publications.
Title Year Publication name Journal Volume Pages Authors Editors ISSN Publisher DOI Location
{ { { { { { { { { { {